For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...

GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...

A target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with ...

Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according ...

For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...

Data submitted to the UK drugs regulator show a total of 82 deaths related to glucagon-like peptide-1 receptor agonists, the class of drugs used for weight loss and type 2 diabetes. Data from the ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...

(res), a leading physician-developed supplement brand, announced today the launch of their latest product innovation, resM™ ...

Recent research found that weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...

Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional ...